Friday Session Schedule
Introduction to Session
The theme for Session 3A is Advanced Breast Cancer.
Systemic Therapy for HER2-Low Advanced Breast Cancer
Stephen Chia
Implications of the FINER Trial Results
Helping Healthcare Workers Help their Patients with Metastatic Breast Cancer
Lesley Fallowfield
Morning Tea Break
Welcome Back to Session
Finding My Way - ADVANCED
Lisa Beatty
Debate: First Line Treatment for Patients with Metastatic ER/HER2- Breast Cancer Should Include a CDK4/6 Inhibitor
Javier Cortes (Y) v Prue Francis (N)
Javier Cortes
Prue Francis
Can Real World Evidence Really Address Real Clinical Questions?
Adam Brufsky
Targeting HRD - The Shift From Late to Early Stage Disease
Stephen Luen
Session Close
GILEAD will hold a Lunch Symposium during the break on Friday 25 July. More information including the program and featured guest speakers for this session will be made available over the upcoming months.
Introduction to Session
The theme for Session 3B is the Breast Cancer Surgical Session.
ANTHEM Study, OPBS Outcomes/ Decision-Making
Shelley Potter
PROMs After Local Therapy
Reshma Jagsi
Fast Forward Boost: Accelerating Breast Cancer Treatment with Ultra Hypo-Fractionated Radiotherapy
Michael Jones
Abstract Presentation
Morning Tea Break
Welcome Back to Session
Presentation of John Collins Medal
The Diminishing Role of Axillary Dissection
Reshma Jagsi - For Axillary Dissection;
Stuart McIntosh - Against Axillary Dissection.
Reshma Jagsi
Stuart McIntosh
TADpole Study
Shelley Potter
Abstract Presentation
VAB-Ex
Gelareh Farshid
Session Close
GILEAD will hold a Lunch Symposium on Friday 25 July. More information including the program and featured guest speakers for this session will be made available over the upcoming months.
Welcome Back to Session
The theme for Session 4 is Early Breast Cancer.
Debate: Nsabp - b51: A Paradigm Shift or Premature Standard in Breast Cancer Care
Gillian Lamoury (For);
Reshma Jagsi (Against).
Reshma Jagsi
Gillian Lamoury
Locoregional Therapy De-Escalation Study Review
Shelley Potter
Adjuvant CDKIs: When, Which and Where is the Threshold for Patients?
Amelia McCartney
Afternoon Tea Break
Welcome Back to Session
The Influence of Genomic Trials on Radiation Therapy/ Optimisation in Early Disease
Reshma Jagsi
De-Escalation of Endocrine Therapy
Kaori Terata
OPTIMA/ Path-for-Young
Belinda Kiely
What is Ahead in Neoadjuvant Therapy?
Javier Cortes
Close of Scientific Sessions and Close ASM
Bruce Mann